Further analysis of the associations between LSM2 protein expression and the clinical features of the 44 patients with SKCM in clinical cohort revealed that high LSM2 protein expression was positively associated with melanoma ulcer, advanced TNM stage, high Clark level, and deep Breslow depth, indicating the oncogenic characteristics of LSM2 in SKCM. Here, LSM2 is linked to melanoma.